Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (11): 1128-1130.DOI: 10.3969/j.issn.1673-8640.2024.11.018
Received:2023-12-03
Revised:2024-07-31
Online:2024-11-30
Published:2024-11-29
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.11.018
| 项目 | HbA/% | HbA2/% | HbX/% | HbA0/% | HbF/% | Abnormal Hb/%（P3） | Hb A1c/% |
|---|---|---|---|---|---|---|---|
| Hb Fukuyama | 94.3 | 2.7 | 0 | 46.5 | 1.1 | 42.0 | 4.0 |
| Hb North Manchester | 94.7 | 2.6 | 0 | 48.1 | 1.8 | 33.9 | 5.1 |
| 参考区间 | 96.4~97.9 | 2.4~3.5 | 0~5 | 4~6 |
| 项目 | HbA/% | HbA2/% | HbX/% | HbA0/% | HbF/% | Abnormal Hb/%（P3） | Hb A1c/% |
|---|---|---|---|---|---|---|---|
| Hb Fukuyama | 94.3 | 2.7 | 0 | 46.5 | 1.1 | 42.0 | 4.0 |
| Hb North Manchester | 94.7 | 2.6 | 0 | 48.1 | 1.8 | 33.9 | 5.1 |
| 参考区间 | 96.4~97.9 | 2.4~3.5 | 0~5 | 4~6 |
| [1] | 叶丹, 唐燕, 张玫. 血红蛋白变异体对糖化血红蛋白检测的影响[J]. 四川大学学报(医学版), 2023, 54(5):1019-1023. |
| [2] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409. |
| [3] | 杨先艳, 邱永红, 班文芬, 等. 贵州黔南州育龄人群地中海贫血基因检测结果分析[J]. 现代预防医学, 2020, 47(21):3963-3967. |
| [4] | 周翔海, 纪玲, 纪立农, 等. 影响糖化血红蛋白临床应用的血红蛋白变异体识别的专家共识[J]. 中国糖尿病杂志, 2023, 31(8):561-570. |
| [5] | HIDAKA K, IUCHI I, MIYAKE K, et al. Hb Fukuyama [beta 77(EF1)His----Tyr]:a new abnormal hemoglobin discovered in a Japanese[J]. Hemoglobin, 1988, 12(4):391-394. |
| [6] | YUAN Y, ZHOU X, GAO L, et al. Silent hemoglobin variant during capillary electrophoresis:a case report[J]. J Diabetes Investig, 2020, 11(4):1014-1017. |
| [7] | WEI L, WEIFENG Z, ZUOLIANG D. Differential effects on HbA1c detection by HPLC and capillary electrophoresis in five types of Hb variants in China[J]. Lab Med, 2023, 54(3):308-316. |
| [8] | 高冉, 程歆琦. 血红蛋白变异体对解读糖化血红蛋白结果的影响[J]. 中华检验医学杂志, 2019, 42(11): 899-903. |
| [1] | CUI Xiaoyang, LIU Guodong, GUO Huijuan, LIAO Zhihong, LIU Yunhong, ZHANG Weifen, CHEN Zirao, WEI Xiaozhu. Roles of serum exosomal CEA，CA15-3 and CA125 in the differential diagnosis of non-small cell lung cancer and benign lung diseases [J]. Laboratory Medicine, 2024, 39(11): 1035-1041. |
| [2] | ZHAO Qiang, XU Xiuwen, HAN Jiaojiao, SONG Ying, MIAO Yingbo, ZHU Peichao, ZHOU Wei, LIN Shiyang, TONG Lanfei, CHE Yiming, JIN Lei, XU Chong. Effect of different preservation methods on stability of samples in external quality assessment of paroxysmal nocturnal hemoglobinuria by flow cytometry [J]. Laboratory Medicine, 2024, 39(11): 1048-1052. |
| [3] | LI Sirui, XU Junyue. Correlation between serum ESM1，DHEA-S and cardiac autonomic neuropathy in patients with type 2 diabetes mellitus [J]. Laboratory Medicine, 2024, 39(11): 1078-1083. |
| [4] | SUN Jiangman, LI Min, MENG Xiangzhao, MA Li, ZHAO Guanglun, YU Hongyuan. Application of total protein standard reference material in frozen human serum in value transfer of reference method [J]. Laboratory Medicine, 2024, 39(11): 1118-1121. |
| [5] | GUO Yuanyuan, SONG Hui, ZHANG Lin. Relationship between FANCF/BRCA1 protein expression and treatment response in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2024, 39(10): 1005-1009. |
| [6] | CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026. |
| [7] | ZHU Longyin, PAN Qianguang, YANG Sha, ZENG Yuqin, FU Chunxiao, PU Youmin, FANG Jia, YAN Chunyan, ZHAO Hongwen. Early warning value of whole blood cell derived inflammatory markers for delayed graft function of renal transplantation [J]. Laboratory Medicine, 2024, 39(10): 939-944. |
| [8] | ZHANG Caili, LUO Xiaohua, YANG Peifeng, LIU Pengli, REN Fang. Prognostic roles of serum FGF2 and FGFR1 in preeclampsia [J]. Laboratory Medicine, 2024, 39(10): 945-949. |
| [9] | HUANG Qian, SHEN Qin, HU Qiuyun, SUN Jing, WAN Pingyin. Predictive values of serum CTRP3 and DKK-1 levels for the occurrence of fractures in postmenopausal osteoporosis patients [J]. Laboratory Medicine, 2024, 39(10): 950-955. |
| [10] | LEI Ming, ZHAI Li, WEI Ying, LIN Yichen, GUO Mengyue. Application of nomogram model based on clinical characteristics and serum tumor markers in differential diagnosis of benign and malignant lung lesions [J]. Laboratory Medicine, 2024, 39(10): 956-962. |
| [11] | TIAN Na, CHEN Shihong, YANG Tao. Correlation between serum METRNL，sTREM-1 levels and carotid atherosclerosis in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2024, 39(10): 963-968. |
| [12] | LI Yanhua, LI Kuo, JI Chunxue, WANG Lixuan, HUANG Shaoyue, GUO Jian, LI Dongxu. Relationship between serum amyloid beta，chitinase 3-like protein 1 levels and carotid artery lesions in patients with ischemic cerebrovascular disease [J]. Laboratory Medicine, 2024, 39(9): 823-827. |
| [13] | LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi. Changes of serum NFL，Cys C and Lp-PLA2 levels in patients with vascular Parkinsonism and their clinical significance [J]. Laboratory Medicine, 2024, 39(9): 828-833. |
| [14] | LI Kun, HU Bingtao, WAN Nan. Roles of serum irisin and soluble Corin in prognosis assessment of elderly patients with chronic heart failure [J]. Laboratory Medicine, 2024, 39(9): 834-840. |
| [15] | FANG Huiling, JU Yi, OU Yuanzhu, ZHU Yuqing, LI Qing, JIN Zhonggan, ZHAO Xiaojun, FAN Xiaoyu, YU Keying. Current status of liquid chromatography-tandem mass spectrometry in clinical laboratories in Shanghai [J]. Laboratory Medicine, 2024, 39(9): 853-858. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
